Works matching IS 11732563 AND DT 2021 AND VI 41 AND IP 4

Results: 10

Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 391, doi. 10.1007/s40261-021-01026-5

By:

Miyachi, Narihisa;
Zagrijtschuk, Oleh;
Kang, Lisa;
Yonezu, Katsuya;
Qin, Albert

Publication type:

Article

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 293, doi. 10.1007/s40261-021-01020-x

By:

Rutman, Matthew P.;
Horn, John R.;
Newman, Diane K.;
Stefanacci, Richard G.

Publication type:

Article

Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 353, doi. 10.1007/s40261-021-01019-4

By:

Buck, Margaret M.;
Haddon, Alexa M.;
Paneccasio, Antonietta;
Skoloda, Daniel J.;
Zimmerman, David E.;
Guarascio, Anthony J.;
Nemecek, Branden D.;
Covvey, Jordan R.;
Montepara, Courtney A.

Publication type:

Article

Cost-effectiveness Analysis of Atezolizumab Plus Nab-Paclitaxel for Advanced PD-L1 Positive Triple-Negative Breast Cancer in Japan.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 381, doi. 10.1007/s40261-021-01017-6

By:

Chisaki, Yugo;
Kuwada, Yoshiki;
Matsumura, Chikako;
Yano, Yoshitaka

Publication type:

Article

Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 341, doi. 10.1007/s40261-021-01016-7

By:

Chen, Hsin-Yu;
Ou, Shih-Hsiang;
Huang, Chien-Wei;
Lee, Po-Tsang;
Chou, Kang-Ju;
Lin, Pei-Chin;
Su, Yi-Chia

Publication type:

Article

Correction to: The CITIMERIVA Study: CITIcoline plus MEmantine plus RIVAstigmine in Older Patients Affected with Alzheimer's Disease.

Published in:

2021

By:

Castagna, Alberto;
Manzo, Ciro;
Fabbo, Andrea;
Lacava, Roberto;
Ruberto, Carmen;
Ruotolo, Giovanni

Publication type:

Correction Notice

Overall Efficacy and Safety of Safinamide in Parkinson's Disease: A Systematic Review and a Meta-analysis.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 321, doi. 10.1007/s40261-021-01011-y

By:

Giossi, Riccardo;
Carrara, Federica;
Mazzari, Martina;
Lo Re, Francesco;
Senatore, Michele;
Schicchi, Azzurra;
Corrù, Federica;
Fittipaldo, Veronica Andrea;
Pani, Arianna;
Tramacere, Irene;
Elia, Antonio Emanuele;
Scaglione, Francesco

Publication type:

Article

Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 371, doi. 10.1007/s40261-021-01013-w

By:

Gourzoulidis, George;
Tzanetakos, Charalampos;
Ioannidis, Ioannis;
Tsimihodimos, Vasilis;
Diogo, Viana;
Karpouzos, George;
Papageorgiou, Giannis;
Kourlaba, Georgia

Publication type:

Article

Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 405, doi. 10.1007/s40261-021-01010-z

By:

Hoy, Sheridan M.

Publication type:

Article

Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 4, p. 303, doi. 10.1007/s40261-021-01000-1

By:

Rognoni, Carla;
Bertolani, Arianna;
Jommi, Claudio

Publication type:

Article